Michael J. Mc Elhaugh Arbutus Biopharma Corp (ABUS) insider trading activity

Michael J. Mc Elhaugh is Interim President & CEO of Arbutus Biopharma Corp. Currently has a direct ownership of 1.66 Million shares of ABUS, which is worth approximately $5.67 Million. The most recent transaction as insider was on Feb 14, 2025, when has been sold 177,000 shares (Common Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.66M

10.18% 3M change

10.18% 12M change

Total Value Held $5.67 Million

Michael J. McElhaugh Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 14 2025	BUY Grant, award, or other acquisition	-	177,000 Added 9.65%	1,658,003 Common Shares
Feb 04 2025	SELL Open market or private sale	$78,031 $3.28 p/Share	23,790 Reduced 1.58%	1,481,003 Common Shares
Feb 02 2024	SELL Open market or private sale	$23,478 $2.31 p/Share	10,164 Reduced 0.67%	1,504,793 Common Shares
Feb 01 2024	BUY Grant, award, or other acquisition	-	123,800 Added 7.55%	1,514,957 Common Shares
Feb 01 2023	BUY Grant, award, or other acquisition	-	83,700 Added 5.68%	1,391,157 Common Shares
Feb 09 2021	SELL Open market or private sale	$100,000 $5.0 p/Share	20,000 Reduced 1.51%	1,307,457 Common Stock
Dec 14 2020	SELL Open market or private sale	$200,000 $5.0 p/Share	40,000 Reduced 2.93%	1,327,457 Common Stock

MJM

Michael J. Mc Elhaugh

Interim President & CEO

Warminster, PA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ABUS shares.

Notify only if

Value

Insider Trading

Get notified when an Arbutus Biopharma Corp insider buys or sells ABUS shares.

Notify only if

Operation

Value

Type

News

Receive news related to Arbutus Biopharma Corp

Track Activities on ABUS

Account